NASDAQ:CPIX

Cumberland Pharmaceuticals Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy CPIX

*Your capital is at risk

$5.61

-0.160 (-2.77%)

At Close: Jun 03, 2026

Cumberland Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 90.33. In total, the insiders bought 127.02K and sold 5.85K CPIX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	90.33
● Buy	127.02K shares
● Sell	5.85K shares
99% Buy Activity Moderate Negative Correlation
Buy Signal High Confidence Mar 18, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 90.33. Confidence increased due to high data reliability score of 90. Supported by overwhelming buy-side pressure (99% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 18, 2026 Buy	Common Stock A-Award	Galante Joseph C Director	Director	1 800 Value: $5K
Mar 18, 2026 Buy	Options (right to buy) A-Award	Kazimi A J Chairman And CEO	CEO / President	100 000 Value: $280.0K
Mar 18, 2026 Buy	Common Stock A-Award	Krogulski Kenneth Director	Director	1 800 Value: $5K
Mar 18, 2026 Buy	Options (right to buy) A-Award	Anthony Todd M. Vice Pres Organizational Dev	Officer	3 000 Value: $8K
Mar 18, 2026 Buy	Options (right to buy) A-Award	Hamm John M. Vp Chief Financial Officer	C-Suite Officer	3 000 Value: $8K
Mar 18, 2026 Buy	Common Stock A-Award	Krogulski Kenneth Director	Director	4 000 Value: $11.2K
Mar 18, 2026 Buy	Common Stock A-Award	Young Caroline Director	Director	1 800 Value: $5K
Mar 18, 2026 Buy	Options (right to buy) A-Award	Bitterman Chris T. Vice Pres Sales & Marketing	Officer	3 000 Value: $8K
Mar 18, 2026 Buy	Options (right to buy) A-Award	Herman James L Vp And Chief Compliance Office	Officer	2 500 Value: $7K
Mar 18, 2026 Buy	Common Stock A-Award	Jones James Director	Director	1 800 Value: $5K
Mar 18, 2026 Buy	Common Stock A-Award	Brown Martin S Jr Director	Director	1 800 Value: $5K
Mar 16, 2026 Sell	Common Stock F-InKind	Kazimi A J Chairman And CEO	CEO / President	5 845 Value: $17.9K
Dec 31, 2025 Buy	Common Stock L-Small	Jones James Director	Director	7 Value: $27
Dec 31, 2025 Buy	Common Stock L-Small	Young Caroline Director	Director	5 Value: $20
Dec 31, 2025 Buy	Common Stock L-Small	Krogulski Kenneth Director	Director	62 Value: $242
Dec 31, 2025 Buy	Common Stock L-Small	Kazimi A J Chairman And CEO	CEO / President	7 Value: $27
Dec 30, 2025 Buy	Common Stock L-Small	Krogulski Kenneth Director	Director	54 Value: $213
Dec 30, 2025 Buy	Common Stock L-Small	Young Caroline Director	Director	2 Value: $8
Dec 30, 2025 Buy	Common Stock L-Small	Jones James Director	Director	8 Value: $32
Dec 30, 2025 Buy	Common Stock L-Small	Kazimi A J Chairman And CEO	CEO / President	8 Value: $32
Dec 29, 2025 Buy	Common Stock L-Small	Kazimi A J Chairman And CEO	CEO / President	8 Value: $32
Dec 29, 2025 Buy	Common Stock L-Small	Jones James Director	Director	8 Value: $32
Dec 29, 2025 Buy	Common Stock L-Small	Krogulski Kenneth Director	Director	54 Value: $217
Dec 29, 2025 Buy	Common Stock L-Small	Young Caroline Director	Director	2 Value: $8
Dec 26, 2025 Buy	Common Stock L-Small	Jones James Director	Director	8 Value: $34

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT CUMBERLAND PHARMACEUTICALS INC.

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxat...

Read Full Profile Here